BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38220428)

  • 21. GDF15 promotes osteosarcoma cell migration and invasion by regulating the TGF‑β signaling pathway.
    Chen G; Wang M; Liu X
    Mol Med Rep; 2019 Nov; 20(5):4262-4270. PubMed ID: 31545486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-124 suppresses growth and aggressiveness of osteosarcoma and inhibits TGF-β-mediated AKT/GSK-3β/SNAIL-1 signaling.
    Yu B; Jiang K; Zhang J
    Mol Med Rep; 2018 May; 17(5):6736-6744. PubMed ID: 29488603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LncRNA LINC00628 overexpression inhibits the growth and invasion through regulating PI3K/Akt signaling pathway in osteosarcoma.
    He R; Wu JX; Zhang Y; Che H; Yang L
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5857-5866. PubMed ID: 30280767
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SATB2 enhances migration and invasion in osteosarcoma by regulating genes involved in cytoskeletal organization.
    Seong BK; Lau J; Adderley T; Kee L; Chaukos D; Pienkowska M; Malkin D; Thorner P; Irwin MS
    Oncogene; 2015 Jul; 34(27):3582-92. PubMed ID: 25220418
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distinct profiles of oxidative stress-related and matrix proteins in adult bone and soft tissue osteosarcoma and desmoid tumors: a proteomics study.
    Rao UN; Hood BL; Jones-Laughner JM; Sun M; Conrads TP
    Hum Pathol; 2013 May; 44(5):725-33. PubMed ID: 23063503
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-27a promotes proliferation, migration and invasion by targeting MAP2K4 in human osteosarcoma cells.
    Pan W; Wang H; Jianwei R; Ye Z
    Cell Physiol Biochem; 2014; 33(2):402-12. PubMed ID: 24556602
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heterozygous retinoblastoma gene mutation compromises in vitro osteogenesis of adipose mesenchymal stem cells - a temporal gene expression study.
    Vincent A; Natarajan V; Khetan V; Krishnakumar S; Parameswaran S
    Exp Cell Res; 2020 Nov; 396(1):112263. PubMed ID: 32890459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. From genomics to metabolomics: emerging metastatic biomarkers in osteosarcoma.
    Dean DC; Shen S; Hornicek FJ; Duan Z
    Cancer Metastasis Rev; 2018 Dec; 37(4):719-731. PubMed ID: 30167827
    [TBL] [Abstract][Full Text] [Related]  

  • 29. p16(INK4A) inhibits the pro-metastatic potentials of osteosarcoma cells through targeting the ERK pathway and TGF-β1.
    Silva G; Aboussekhra A
    Mol Carcinog; 2016 May; 55(5):525-36. PubMed ID: 25728247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exosome-transmitted linc00852 associated with receptor tyrosine kinase AXL dysregulates the proliferation and invasion of osteosarcoma.
    Li Q; Wang X; Jiang N; Xie X; Liu N; Liu J; Shen J; Peng T
    Cancer Med; 2020 Sep; 9(17):6354-6366. PubMed ID: 32673448
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MiR-133b is down-regulated in human osteosarcoma and inhibits osteosarcoma cells proliferation, migration and invasion, and promotes apoptosis.
    Zhao H; Li M; Li L; Yang X; Lan G; Zhang Y
    PLoS One; 2013; 8(12):e83571. PubMed ID: 24391788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CCN2 enhances resistance to cisplatin-mediating cell apoptosis in human osteosarcoma.
    Tsai HC; Huang CY; Su HL; Tang CH
    PLoS One; 2014; 9(3):e90159. PubMed ID: 24637722
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical significance of microRNA-183/Ezrin axis in judging the prognosis of patients with osteosarcoma.
    Mu Y; Zhang H; Che L; Li K
    Med Oncol; 2014 Feb; 31(2):821. PubMed ID: 24352761
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Roles of microRNA-206 in osteosarcoma pathogenesis and progression.
    Bao YP; Yi Y; Peng LL; Fang J; Liu KB; Li WZ; Luo HS
    Asian Pac J Cancer Prev; 2013; 14(6):3751-5. PubMed ID: 23886177
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cancer stem cells in osteosarcoma.
    Brown HK; Tellez-Gabriel M; Heymann D
    Cancer Lett; 2017 Feb; 386():189-195. PubMed ID: 27894960
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Delineation of hypoxia-induced proteome shifts in osteosarcoma cells with different metastatic propensities.
    Song Z; Pearce MC; Jiang Y; Yang L; Goodall C; Miranda CL; Milovancev M; Bracha S; Kolluri SK; Maier CS
    Sci Rep; 2020 Jan; 10(1):727. PubMed ID: 31959767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overexpression of smad7 blocks primary tumor growth and lung metastasis development in osteosarcoma.
    Lamora A; Talbot J; Bougras G; Amiaud J; Leduc M; Chesneau J; Taurelle J; Stresing V; Le Deley MC; Heymann MF; Heymann D; Redini F; Verrecchia F
    Clin Cancer Res; 2014 Oct; 20(19):5097-112. PubMed ID: 25107916
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long non-coding RNA ASBEL promotes osteosarcoma cell proliferation, migration, and invasion by regulating microRNA-21.
    Zhao J; Zhang C; Gao Z; Wu H; Gu R; Jiang R
    J Cell Biochem; 2018 Aug; 119(8):6461-6469. PubMed ID: 29323740
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of ezrin in osteosarcoma metastasis.
    Ren L; Khanna C
    Adv Exp Med Biol; 2014; 804():181-201. PubMed ID: 24924175
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Crosstalk between ATF4 and MTA1/HDAC1 promotes osteosarcoma progression.
    Zeng H; Zhang JM; Du Y; Wang J; Ren Y; Li M; Li H; Cai Z; Chu Q; Yang C
    Oncotarget; 2016 Feb; 7(6):7329-42. PubMed ID: 26797758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.